MedTrace Logo

CBD Effects on Periodontal Health of Patients With Chronic Periodontitis

NCT05498012 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2022-08-11

No results posted yet for this study

Summary

The suppression of chronic periodontitis after application of dental gel and toothpaste containing cannabidiol (CBD) will be evaluated.

Conditions

  • Chronic Periodontitis

Interventions

COMBINATION_PRODUCT

placebo dental gel, placebo toothpaste

* Placebo dental gel applied by dentist after oral hygiene; without cannabidiol. * Placebo toothpaste; without cannabidiol. For daily use by patient.

COMBINATION_PRODUCT

Cannabidiol dental gel, Cannabidiol toothpaste

* Cannabidiol dental gel applied by dentist after oral hygiene; containing 1 % (w/w) cannabidiol. * Cannabidiol toothpaste; containing 1 % (w/w) cannabidiol. For daily use by patient.

COMBINATION_PRODUCT

Placebo toothpaste, Corsodyl dental gel

* Corsodyl dental gel; containing 1 % (w/w) chlorhexidini digluconatis applied by dentist after oral hygiene. * Placebo toothpaste; without cannabidiol. For daily use by patient.

Sponsors & Collaborators

  • CB21 Pharma Ltd.

    collaborator UNKNOWN

  • Palacky University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-05
Primary Completion
2022-01-27
Completion
2022-02-01

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05498012 on ClinicalTrials.gov